Dr. Pooja Prem Advani, MD

Dr. Advani practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Advani's NPI, 1386876928, was assigned on August 16, 2009. Dr. Advani graduated from Dr. DY Patil Medical College in 2007. Dr. Advani holds Florida license ME113562.

Dr. Advani's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Advani's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville. Dmand AI also links Dr. Advani to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Advani practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Advani's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Advani is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Advani's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists dry eye, fibromyalgia and chronic pain, gastrointestinal bleeding, hypercalcemia, joint pain, lower back pain, muscle pain, fibromyalgia, and limb pain and neutropenia among the conditions Dr. Advani treats.

CMS data shows 515 Medicare services from Dr. Advani across 7 procedure codes in 2024, for 265 Medicare patients. Medicare paid $49,519 for them. Every service was in an office.

CMS counts 265 Medicare patients who saw Dr. Advani in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have cancer, and 74% have high cholesterol. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Advani's median patient age at 66, with 87% women.

In 2024, Dr. Advani wrote 360 Medicare Part D claims for 121 patients. 85% of them were for generic drugs. CMS names the drug for 262 of them, across 6 drugs with 11 or more claims each, at $315,858 in total drug cost. In 2023, CMS named 181 claims across 4 drugs.

Dr. Advani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Advani as offering telehealth.

Dmand AI links 48 papers to Dr. Advani, published from 2011 to 2025. 2015 was the busiest year, with 6. The most frequent topics are Breast Neoplasms, Antineoplastic Agents and Multiple Myeloma. Dr. Advani has published most often in Ann Hematol. Dr. Advani's most frequent co-authors are Saranya Chumsri, MD, Asher A. Chanan-Khan, MD and Abhisek Swaika, MBBS.

Dmand AI links Dr. Advani to 3 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 79 general payments to Dr. Advani from 20 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 48% of the total. Stemline Therapeutics Inc. paid the most, $22,824.

Dr. Advani graduated from Dr. DY Patil Medical College in 2007.

Dr. Advani is in network with 11 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.